COVID-19: como informações baseadas em evidências auxiliaram um hospital terciário durante o primeiro ano pandêmico / COVID-19: how evidence-based information supported a tertiary hospital during the first pandemic year

Introdução: Durante a pandemia de COVID-19, a necessidade por uma informação confiável, rápida e precisa desafiou os profissionais de saúde de todo o mundo. O objetivo deste trabalho foi avaliar e comparar as solicitações dos profissionais da saúde realizadas a um Centro de Informação Sobre Medicamentos (CIM) em um ano pré-pandêmico e durante o primeiro ano pandêmico. Métodos: Trata-se de um estudo quantitativo e retrospectivo, que analisou as perguntas realizadas ao CIM do Instituto Central do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (ICHCFMUSP) quanto ao seu assunto, classificação ATC dos medicamentos envolvidos e profissionais solicitantes. Resultados: Os resultados demonstram que, de maneira geral, durante o primeiro ano pandêmico houve um aumento de 454 perguntas (66,13%; p < 0,01). As dúvidas se referiam principalmente a questões de administração, estabilidade/compatibilidade e padronização do medicamento na instituição, sendo o farmacêutico o profissional que realizou maior número de questionamentos. Ao seccionar as perguntas, verificou-se que a maioria das informações solicitadas se referiram a agentes infecciosos, agentes que atuam no sangue/órgãos hematopoiéticos e sistema nervoso. Conclusão: Considerando o cenário pandêmico, com sobrecarga dos serviços de saúde, contratação em massa de novos profissionais e pouca disponibilidade de informações com embasamento científico, as evidências fornecidas pelo CIM, aliadas ao entendimento do quadro clínico de cada paciente, com certeza auxiliaram em um melhor desfecho clínico, bem como foram essenciais no uso racional de medicamentos no combate a pandemia de COVID-19.

Introduction: During the COVID-19 pandemic the need for reliable, fast and accurate information challenged healthcare professionals around the world. The aim of this study was to evaluate and compare the requests made by health professionals to a Drug Information Center (DIC) in a pre-pandemic year and during the first year of the pandemic. Methods: This is a quantitative and retrospective study that analyzed the solicitations made to the DIC of the Instituto Central do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (ICHCFMUSP) regarding its subject, ATC classification of drugs involved and requesting professionals. Results: The results show that, in general, during the first pandemic year there was an increase of 454 questions (66.13%; p < 0.01). The questions referred mainly to issues of administration, stability/compatibility and standardization of the medicines in the institution, being the pharmacist the professional who asked the most number of questions. When sectioning the questions, it was found that most of the information requested referred to infectious agents, agents that act on the blood/hematopoietic organs and the nervous system. Conclusion: Considering the pandemic scenario, with an overload of health services, large number of hires of new professionals and lack of availability of scientifically based information, the evidence provided by the DIC, combined with the understanding of clinical condition of each patient, certainly helped in a better outcome for each patient, as well as being essential in the rational use of medicines in the fight against the COVID-19 pandemic.

Descripción de la disponibilidad y normas para el uso de las benzodiacepinas en algunos países de América Latina, 2022 / Description of benzodiazepines availability and regulation in several countries of Latin America, 2022 / Descrição da disponibilidade e regulamentação para o uso de benzodiazepínicos em alguns países da América Latina, 2022

Resumen: Introducción: las benzodiacepinas constituyen un grupo farmacológico de amplia prescripción a nivel mundial desde su aparición en la década de 1960. El objetivo del presente estudio fue identificar la disponibilidad, las modalidades de prescripción y dispensación de benzodiacepinas en diferentes países de América Latina, según reglamentación vigente en cada país participante del estudio. Materiales y métodos: estudio observacional, descriptivo y transversal, realizado con los datos disponibles al año 2022 de todos los países miembros de la Red de Centros de Información de Medicamentos de LatinoAmérica y el Caribe (Red CIMLAC) que fueron parte del estudio. Se utilizaron las bases de datos de las agencias regulatorias, la reglamentación vigente y otros documentos necesarios para obtener la información sobre la dispensación y prescripción en cada país. Resultados: doce de los 20 países de la Red CIMLAC completaron el estudio. El total de benzodiacepinas disponible en cada país varió entre 6 y 12 (media: 9). De ellas, en promedio 5 estaban incluidas en listados de medicamentos esenciales nacionales. La mayoría de los países cuentan con combinaciones a dosis fijas con benzodiacepinas. En todos los países se realiza la prescripción por receta especial. Más de la mitad de los países cuentan con recomendaciones nacionales. Conclusiones: la amplia disponibilidad de benzodiacepinas comercializadas, la existencia de combinaciones a dosis fijas y la falta de recomendaciones nacionales pueden ser factores que contribuyan al uso irracional de este grupo terapéutico.

Summary: Introduction: benzodiazepines constitute a widely prescribed group of drugs around the world, since they appeared in the sixties. This study aims to identify the availability, prescription modalities and dispensing of benzodiazepines in different countries around Latin America, as per the legal provisions in force in each of the countries participating in the study. Method: observational, descriptive, transversal study based on the information available in 2022 about all the member countries of the Network Medicines Information Centers of Latin America and the Caribbean (CIMLAC Network) that were part of the study. The databases of regulatory authorities were used and the legal provisions in force and relevant documents were consulted in order to obtain information on benzodiazepines dispensing and prescription in each country. Results: twelve out of the 20 CIMLAC Network member countries completed the study. The total number of benzodiazepines available in the study ranged from 6 to 12 (mean was 9), and 5 of them on average were included in the national essential medications lists. Most countries have benzodiazepines fixed dose combinations and in all countries a special medical prescription is needed. More than half of the countries have national recommendations. Conclusions: the wide availability of benzodiazepines in the market, the existence of fixed-dose combinations and the lack of national recommendations may constitute factors that contribute to the irrational use of this group of drugs.

Resumo: Introdução: os benzodiazepínicos constituem um grupo farmacológico amplamente prescrito em todo o mundo desde seu surgimento na década de 1960. O objetivo deste estudo foi identificar a disponibilidade, prescrição e modalidades de dispensação de benzodiazepínicos em diferentes países da América Latina, de acordo com as regulamentações vigentes em cada país participante do estudo. Materiais e métodos: estudo observacional, descritivo e transversal, realizado com os dados disponíveis até o ano de 2022 dos países membros da Rede de Centros de Informação sobre Medicamentos da América Latina e do Caribe (Red CIMLAC) que faziam parte do estudo. As bases de dados das agências reguladoras, normas vigentes e outros documentos necessários foram utilizados para obter informações sobre dispensação e prescrição em cada país. Resultados: doze dos 20 países da Rede CIMLAC completaram o estudo. O número total de benzodiazepínicos disponíveis em cada país variou entre 6 e 12 (média: 9). Destes, uma média de 5 foram incluídos nas listas nacionais de medicamentos essenciais. A maioria dos países tem combinações de dose fixa com benzodiazepínicos. Em todos os países é necessário prescrição especial. Mais da metade dos países têm recomendações nacionais. Conclusões: a ampla disponibilidade de benzodiazepínicos comercializados, a existência de combinações em doses fixas e a falta de recomendações nacionais podem ser fatores que contribuem para o uso irracional desse grupo terapêutico.

Actual Use of Internet by Patients with Diabetes to Find Drug Information / 医薬品情報学

Objectives: It is important for patients to make correct use of drug information (DI) to promote the proper use of medicines. Many patients use the Internet to find DI, but awareness about the websites of public institutions that provide DI is low. This study aimed to identify the actual use of the Internet for DI and associated problems to inform development of a comprehensive DI website for patients.Method: Patients with diabetes were set as a model case for patients who take medicines and need DI. A questionnaire survey was conducted among patients with diabetes who visited community pharmacies in Kagoshima City from March 2019 to October 2019. The survey covered Internet use, DI needs, methods of sourcing DI, and problems obtaining DI via the Internet.Results: There were 349 valid respondents (median age 64 years), of which 52.1% used the Internet at least once a week. Around half of the Internet users searched for DI on the Internet. More than half of these respondents chose a DI acquisition site because it “appeared at the top of search results” and was “easy to understand.” However, around half of these respondents felt that “there is too much information on the internet and I don’t know what is correct.”Conclusion: This study suggests that older patients with a long history of diabetes use the Internet to obtain DI. However, patients face various problems accessing DI via the Internet. It may be necessary to construct a comprehensive website that is easy to use and enhance public health literacy to support the proper use of medicines by patients.

Japanese Medical Academic Organizations Surveyed on the Current Situation of Medical Information Providedto the Public on the Internet / 医薬品情報学

Objective: The internet isflooded with drug information; however, some of it isinappropriate and thisinadequate information could expose the public to health hazards. Therefore, we conducted research on the idea of transmitting drug information to the public via the internet and the current state of the information currently provided by each academic society relevant to the field of Medical Informatics.Methods: A questionnaire was mailed to the website managers for the website of 129 specialist medical societies, all members of the Japanese Association of Medical Sciences. We conducted our research between October to November 2018. We investigated each website administrator’s opinion about offering drug information for consumers via the internet and what information each academic society is currently providing.Results: The effective response rate was 43.4% (56/129 groups). Most respondents thought that drug information overflowed in the current Internet society. Moreover, more than half of the respondents thought that the quality of drug information transmitted to the public wasinadequate. Currently, 30 of the academic groupssurveyed are providing information to the public. When providing information, they did not refer to the “Drug Guide for Patients” much. More than 80% of respondents said they would cooperate with linking to the information provided to the public. However, each academic society felt there would be many problems with doing so such as the need for a system to check the contents of the information provided and a system to perform maintenance.Conclusion: The results showed that the website administrators recognized that there is a need to improve the quality of and system for providing drug information to the public. We believe that an integrated information system can be constructed by aggregating the drug information held by each academic society. However, this cannot be realized without first solving many problems.

Needs And Utilization Of Drug-Information Resources Of Healthcare Providers In An Academic Tertiary Care Center

Objective: To investigate the drug-related information needs of healthcare providers (HCPs), their utilization of drug information resources as well as the main factors influencing the selection of resources. Methods: A total of 393 HCPs were conveniently selected and invited to complete a questionnaire. Stratified sampling was used for the three subpopulations of physicians, pharmacists, and nurses. The questionnaire was coded, validated, and analyzed using the Statistical Package for the Social Sciences (SAS version 9.2). Results: Of 450 HCPs approached, 393 completed the questionnaire (response rate 87%). Information related to drug dosage/administration, indications, and interactions is the most frequently required, 47%, 44%, and 34%, respectively. The majority of the sample perceived the Internet (69.47%) and electronic databases (67.43%) as “very useful.” Printed materials (46.56%) and Personal Digital Assistants (PDAs) (44.78%) or calling the pharmacy (43.26%) were also useful resources of information followed by using electronic books and journals (38.42%) and asking colleagues (32.32%). The majority (53.18%) described consulting a clinical pharmacist as “very useful.” However, 16% of the nurse group and 35% of the physician group were not aware of the existence of the Drug Information Center (DIC) and more than 8% of the participants consider calling the DIC about drug-related information “not useful”. Conclusion: Digital resources are used by HCPs more frequently than traditional resources, consulting a clinical pharmacist or calling the DIC. Providing reliable electronic resources and raising the awareness of HCPs regarding the role of a clinical pharmacist and DIC for patient-specific therapies should be instituted.

Assessment and evaluation of drug information services provided by drug information centre at a multispecialty hospital in Erode, Tamil Nadu, India

Background: To evaluate the performance of Drug Information Centre (DIC) in providing quality drug information services to the health care professionals.Methods: It was a prospective study carried out for a period of six months (June-November 2017). The drug information services provided by the pharmacist at the DIC during ward rounds, direct access, telephone and mail were documented in the drug information request and documentation forms. The quality of drug information provided was assessed with the help of feedback questionnaire which was filled by receivers.Results: A total of 283 queries were received, with a maximum from ward rounds 140(49.47%). On evaluation, it was found that most of the queries were from physicians 207 (73.14%) followed by nurses 33(11.66%), pharmacists 26 (9.18%), patients 17 (6.07%). Among that 178 (62.89%) queries were received from department of general medicine. Most of the queries were intended to update knowledge 110 (38.86%) and for the purpose of better patient care 90 (31.81%). The time frame for an authentic reply ranged from minutes to 24 hours, where a maximum of 110 (38.86%) queries had sent a 24 hours deadline. The majority of the queries were for adverse drug reactions [ADR-60 (21.20%)] and most preferred resources were primary 188 (66.43%).Conclusions: The DIC has always presented and offered itself to be an impressive resource, which is used routinely as an information source by all levels of professionals involved in the health system, in addition to the patients themselves.

Actual Condition Survey of Risk and Benefit Communication for Consumers and Patients on Pharmaceuticals / 医薬品情報学

Objective:It is necessary to obtain appropriate drug information (DI)so that appropriate medical care is provided for the consumers,patients. Thorough studies have not been done on institutions that offer DI for patients in Japan and the state of its dissemination. The purpose of this study is to find levels of recognition of the institutions providing medical information and the actual state of its usage.Method:In order to find the levels of recognition of the institutions that provide DI to general consumers and the state of usage of the information provided by them,we conducted questionnaire surveys using online panels. We also conducted a study to find subjective comprehension on DI by the panels. The surveys were conducted twice using the same questionnaire in order to robust the outcomes of the study.Results:We received 1,095 valid responses from the first survey and 1,086 from the second survey respectively. No significant differences were found between the two surveys. Although the levels of recognition vary for the four representative public institutions providing DI,DI provided by these institutions has been barely utilized by the respondents. As the sources of DI that have been used most,almost the same numbers of respondents replied that they used Internet search engines to access them in addition to medical doctors and pharmacists. Regarding the levels of comprehension for the provided DI,the respondents tended to have shown high levels of understanding on maintaining medication compliance,but low on safety information. There was a positive correlation between age and the understanding of the DI.Conclusion: The study implies that the environment to provide DI for patients still needs to be improved, and the respondents didnʼt understand DI enoughly. Therefore,it is necessary to study further for the creation and communication of truly user-friendly DI.

Prevalence and risk factors of inadequate medicine home storage: a community-based study

ABSTRACT OBJECTIVE Assess the extent of inadequate home storage of medicines andidentify important risk factors. METHODS A cross-sectional survey based on a probability sample in the community, conducted in 267 households in Cuité, State of Paraíba, Northeast Brazil, in 2014. Logistic regression was used to study the risk factors. RESULTS The prevalence of households with inadequate storage was 76.0%. Problems with storage include direct exposure to sunlight in 10.9% of households, the presence of dust in 23.6%, and storage within reach of children in 76.0%. Medications no longer used are usually disposed of into the environment in 92.1% of households. Inadequate storage is more likely when home organization of medications is the responsibility of a male subject (OR = 1.729) or an older person (OR = 1.029), when out of date medicines are found (OR = 2.963), and in households with no children (OR = 2.088). CONCLUSIONS Physicians and pharmacists should advise patients on how to adequately store medicines at home, especially when the person in charge of medications is a male or an older adult, and if there are no children in the household.

Pharmacy Information Systems in Teaching Hospitals: A Multi-dimensional Evaluation Study / 대한의료정보학회지

OBJECTIVES: In hospitals, the pharmacy information system (PIS) is usually a sub-system of the hospital information system (HIS). The PIS supports the distribution and management of drugs, shows drug and medical device inventory, and facilitates preparing needed reports. In this study, pharmacy information systems implemented in general teaching hospitals affiliated to medical universities in Tehran (Iran) were evaluated using a multi-dimensional tool. METHODS: This was an evaluation study conducted in 2015. To collect data, a checklist was developed by reviewing the relevant literature; this checklist included both general and specific criteria to evaluate pharmacy information systems. The checklist was then validated by medical informatics experts and pharmacists. The sample of the study included five PIS in general-teaching hospitals affiliated to three medical universities in Tehran (Iran). Data were collected using the checklist and through observing the systems. The findings were presented as tables. RESULTS: Five PIS were evaluated in the five general-teaching hospitals that had the highest bed numbers. The findings showed that the evaluated pharmacy information systems lacked some important general and specific criteria. Among the general evaluation criteria, it was found that only two of the PIS studied were capable of restricting repeated attempts made for unauthorized access to the systems. With respect to the specific evaluation criteria, no attention was paid to the patient safety aspect. CONCLUSIONS: The PIS studied were mainly designed to support financial tasks; little attention was paid to clinical and patient safety features.

Producción científica relativa a los servicios de Información de medicamentos en la web of science / Scientific production on drug information services in the web of science

INTRODUCCIÓN: la actividad de los servicios de información sobre medicamentos ha evolucionado desde la aparición de estos hasta la actualidad, de la misma forma que el análisis de tales servicios por la literatura científica. En concordancia con dicha realidad, el presente trabajo pretende caracterizar la producción científica relativa a los servicios de información de medicamentos dentro de la base de datos Web of Science. MÉTODOS: se desarrolló un estudio descriptivo, longitudinal y retrospectivo de la producción científica relativa a los servicios de información sobre medicamentos en la Web of Science. Se utilizó una estrategia de búsqueda bilingüe empleando los términos «Drug Information Services¼ y «Servicio de Información sobre Medicamentos¼, y se recuperaron todos los artículos científicos relacionados con los términos mencionados entre 1972 y octubre de 2013. Todos los datos recopilados fueron procesados mediante el gestor bibliográfico Endnote X5; las matrices de coocurrencia se obtuvieron empleando el software Bibexcel, mientras que para la visualización de las redes de colaboración se empleó el programa Ucinet 6. Se estudiaron seis indicadores unidimensionales y cinco bidimensionales. RESULTADOS: la cifra de artículos recuperados ascendió a 105 (76,19 % originales). La mayor productividad se observó en el quinquenio 2004-2008 con 28 documentos; Estados Unidos, Alemania y Finlandia fueron las naciones más productivas. Se identificaron 299 autores, entre los cuales Pohjanoksa-Mantyla MK. y Haefeli WE fueron los más prolíficos. No se encontró una colaboración autoral, institucional o internacional significativa.

INTRODUCTION: the activity of drug information services has developed since the appearance of drugs until the present days, as well as, since the analysis of those services was expressed in the scientific literature. According to this fact, the present work has as objective to characterize scientific production related to drug information services taking as reference the Web of Science database. METHODS: a retrospective, longitudinal and descriptive study of the scientific production related to drug information services in the Web of Science was carried out. A strategy of bilingual searching was used writing the terms «Drug Information Services¼ and «Servicio de Información sobre Medicamentos¼, and it allowed us to gather all scientific articles related to the mentioned terms from 1972 and October, 2013. All compiled data were processed by means of the bibliographic database Endnote X5; co-occurrence matrices were obtained using Bibexcel software, while Ucinet 6 program was used for the visualization of collaborative networks. Six unidimensional and five bidimensional measurements were studied. RESULTS: the number of recovered articles reached to 105 (76,19 % originals). The greatest productivity was observed from 2004 to 2008 with 28 documents; United States of America, Germany and Finland were the most productive countries. There were identified 299 authors, such as, Pohjanoksa-Mantyla MK. y Haefeli WE. who were the most prolific ones. There was not a significant author, institutional or international collaboration.

Preparation of a Drug Information Database Application Using FileMaker Go® / 医薬品情報学

<b>Objective: </b>We aimed to develop software that could provide drug information off-line using a smart device.  Therefore, FileMaker Go® was examined and evaluated as a mobile drug information application.<br><b>Methods: </b>A mobile drug information database (Mobile DI-DB) application was created using FileMaker Go®.  The function, search performance, and characteristics of Mobile DI-DB were evaluated.  In addition, question and answer time with Mobile DI-DB was compared with that existing drug information database (existing DI-DB) of the Soka Municipal Hospital.<br><b>Results: </b>Mobile DI-DB can be viewed on an iPad®and iPhone®.  The software is full-text searchable, has good search performance, and is characterized by a small file size.  Furthermore, question and answer times were found to be shorter about 1/3 with Mobile DI-DB than with existing DI-DB.<br><b>Conclusion: </b>A mobile drug information database prepared with Filemaker Go® can now be viewed on a smart device, making drug information easier to access than ever before.  Although this study focused on increasing operational efficiency of pharmacists through the use of the Mobile DI-DB application, we believe that this application can benefit other users too.

Autoridades reguladoras de medicamentos sul-americanas: uma análise a partir de regras organizacionais / Drug regulatory authorities in South America: an analysis based on organizational rules

OBJETIVO: Descrever a organização das autoridades reguladoras nacionais (ARN) de medicamentos da Argentina, Brasil, Chile e Peru pela análise de categorias representativas de regras organizacionais. MÉTODOS: As ARN estudadas foram selecionadas utilizando-se os seguintes critérios: estar em país da América do Sul, ter sido identificada como ARN nos Encuentros de Autoridades Competentes en Medicamentos de los Países Iberoamericanos e apresentar boa disponibilidade de dados eletrônicos sobre estrutura e processo da regulação de medicamentos. Como principal fonte de dados, foram consultadas páginas eletrônicas entre maio de 2010 e março de 2011. As categorias analíticas foram: estrutura da organização, competências, direcionalidade e formas de responsabilidade e prestação de contas. RESULTADOS: As ARN da Argentina e do Brasil funcionavam como agências autônomas, enquanto que as do Chile e do Peru se subordinavam diretamente aos respectivos ministérios da saúde. À exceção da ARN brasileira, evidenciou-se a dependência das demais em relação ao ministério para emitir normas sanitárias. O escopo de ação de cada autoridade se diferenciou pelos bens e serviços a ela sujeitos, sendo a do Peru a única dedicada exclusivamente à regulação de medicamentos. As quatro ARN realizam todos os processos apontadas pela Organização Mundial da Saúde como essenciais para uma regulação efetiva. CONCLUSÕES: Os resultados apontam para um esforço dos países estudados em melhorar sua estrutura regulatória. Não obstante, em diversos aspectos, as quatro ARN ainda precisam aprimorar mecanismos para garantir, ao final da cadeia regulatória, a qualidade e a segurança dos medicamentos por elas regulados, com mais transparência nos processos decisórios e prestação de contas à sociedade.

OBJECTIVE: To describe the organization of national drug regulatory authorities (DRAs) in Argentina, Brazil, Chile, and Peru through the analysis of categories representing organizational rules. METHODS: The DRAs were selected using the following criteria: being in a South American country, having been identified as DRAs at Encuentros de Autoridades Competentes en Medicamentos de los Países Iberoamericanos (Conferences of Ibero-American Drug Regulatory Authorities), and having good availability of electronic data regarding organizational structure and the process of drug regulation. The main source of data were websites, which were reviewed between May 2010 and March 2011. The analytical categories were: organizational structure, competencies, directionality (mission and vision statements), and forms of accountability. RESULTS: The DRAs of Argentina and Brazil functioned as autonomous agencies, while those of Chile and Peru were directly subordinated to the ministries of health. Except for the Brazilian DRA, the agencies in the other three countries were dependent on their health ministries to issue sanitary regulations. The scope of action of each DRA differed in terms of the goods and services covered, with the Peruvian DRA being the only one exclusively dedicated to the regulation of drugs. The four DRAs performed all the processes identified by the World Health Organization as essential for effective drug regulation. CONCLUSIONS: The results show an effort by the studied countries to improve their regulatory structure. Nevertheless, all four DRAs need to improve some mechanisms to ensure that, at the end of the regulatory chain, the drugs they regulate have the desired quality and safety, with more transparency in decision-making processes and social accountability.

Servicio de información de medicamentos: experiencia desde un hospital de alta complejidad de la ciudad de Bogotá, Colombia, 2010-2011 / Drug information services: An experience from a high complexity hospital in Bogotá, Colombia, 2010-2011

Pese a que Colombia cuenta con varios centros y servicios de información de medicamentos, no se han realizado todavía estudios de caracterización de las consultas efectuadas a los mismos. El presente es un estudio descriptivo retrospectivo, elaborado con las solicitudes de información pasiva realizadas al Servicio de Información de Medicamentos del Hospital Universitario San Ignacio de la ciudad de Bogotá, desde abril de 2010 hasta diciembre de 2011. Hubo 197 solicitudes de información, que equivalen a nueve solicitudes por mes y se hicieron 232 preguntas, es decir, once por mes. El 79,2% de las solicitudes se resolvieron el mismo día de consulta. El 77,2% de los consultantes fueron enfermeros. El 69% de las solicitudes las realizaron los servicios asistenciales. La Oficina de Medicamentos No POS fue el servicio que más consultó. La estabilidad, administración y preparación de medicamentos fueron los temas más frecuentemente consultados. El 38,6% de consultas se realizaron por vía telefónica y el 67% se respondieron por correo electrónico. Se concluye que la productividad del servicio fue similar a la de las instituciones de otros países, pero existen diferencias en cuanto al volumen de preguntas, tipo de consultantes y vías de comunicación.

Although Colombia has several drug information services and centers, there aren't studies about the information requests to this institutions. This is a retrospective and descriptive study, conducted with data from the requests for passive information to the Drug Information Service of the San Ignacio University Hospital in Bogotá, since April 2010 until December 2011. There were 197 requests for information, equivalent to 9 per month; and 232 questions, equivalent to 11 per month. 79.2% of requests were resolved the same day of consultation. 77.2% of the consultants were nurses. 69% of requests were made by health services. The Office of Medicines not included in the Mandatory Benefit Plan was the service that most queries made. The stability, the administration and preparation of drugs were the most frequently consulted. 38.6% of consultations were conducted by telephone and 67.0% were answered by email. The study concludes that the service productivity was similar to that in other institutions but there are differences in volume of questions, consultants and communication ways.

Drugs dispensed at the Division of Neonatology at University Hospital in Río Cuarto, Córdoba, Argentina / Medicamentos dispensados al Servicio de Neonatología de un hospital de Río Cuarto, Córdoba

Introduction. The objective was to analyze the number of drugs dispensed by the Pharmacy Department to the Neonatology Division, to find out if the use of these drugs is described on the package insert approved by the Administración Nacional de Medicamentos, Alimentos y Tecnología, ANMAT (Drug, Food and Technology Administration of Argentina) and to compare such information with that provided by Medical Associations and Commissions. Population and methods. Analytical, observational and retrospective study in which drugs were analyzed based on dosage units, costs and relevance in the 2011 annual budget. We analyzed the information found in ANMAT-approved label inserts, in the Neonatal Pharmacopeia of the Sociedad Argentina de Pediatría and in the Formularies of the Confederación Médica Argentina and the Comisión Nacional del Medicamento (National Medication Commission). Results. A total of 102 drugs (91 drug substances) were dispensed throughout 2011. Drugs most commonly supplied were: antiinfective agents for systemic use (24.51%), agents for the blood and blood forming organs, cardiovascular system, and nervous system (12.72% each). The total expenditure was ARS 263,285.52. Only 21 drugs accounted for 90.73% of the cost. Out of the 14 drugs in this group, only 1 had information related to its use in neonatology in all its labels (package inserts), only 4 in some of their product information and there was no information at all in any of the remaining 9 drugs. The Neonatal Pharmacopeia reported on 12 of the 14 drugs, while the Formularies made a reference to 9 of the 14 drugs. Conclusions. The most widely used drugs were antiinfectives for systemic use. A total of 21 drugs accounted for 90.73% of the annual cost in drugs. Out of 14, only 1 had information of its use in neonatology in all its labels and 9 corresponded to off-label use.

Introducción. El objetivo de este trabajo fue analizar la cantidad de medicamentos dispensados por el Servicio de Farmacia al Servicio de Neonatología, indagar si el uso de estos medicamentos en neonatología está descrito en los prospectos autorizados por la Administración Nacional de Medicamentos, Alimentos, y Tecnología Médica (ANMAT) y comparar esa información con la brindada por Sociedades y Comisiones Médicas. Población y métodos. Estudio analítico, observacional y retrospectivo, en que se analizaron los fármacos en unidades posológicas, costos e importancia en el presupuesto anual 2011. Se analizó la información contenida en los prospectos aprobados por la ANMAT, en el Vademécum Neonatal de la Sociedad Argentina de Pediatría y en los Formularios de la Confederación Médica Argentina y de la Comisión Nacional del Medicamento. Resultados. Durante 2011 se dispensaron 102 medicamentos (91 fármacos). Los suministrados con más frecuencia fueron: antiinfecciosos de uso sistémico (24,51%), medicamentos para sangre y órganos hematopoyéticos, sistema cardiovascular y sistema nervioso (12,72% cada uno). El gasto total fue de 263 285,52 pesos. Sólo 21 medicamentos representaron el 90,73% del costo. De 14 medicamentos de este grupo, 1 tenía información sobre neonatología en todos sus prospectos, 4 solo en alguna de sus presentaciones y en 9 no se mencionaba. El Vademécum Neonatal informaba sobre 12/14 medicamentos, mientras que los Formularios contenían 9/14. Conclusiones. Los medicamentos más usados fueron los antiinfecciosos sistémicos. Veintiún medicamentos representaron el 90,73% del costo anual en fármacos. De 14 de ellos, solo 1 tenía información en todos los prospectos para su uso en neonatología y 9 se utilizaron sin licencia.

Construction Case with an Electronic Hospital Formulary to Be Able to Do Rapid Retrieval Using a Portable Terminal iPhone® / 医薬品情報学

<b>Objective: </b>The hospital is changing its formulary reference from paper-based to intranet.  There was concern that both paper-based and intranet versions of the formulary would be necessary.  Revising the paper-based hospital formulary each time package inserts are revised is difficult.  For your review we report on the creation of the iPhone® electronic formulary which enables rapid off-line formulary retrieval and easy updates while at the same time providing low cost service in a light device.<br><b>Methods: </b>The CSV (Comma Separated Value) of the hospital formulary dictionary was made using a standard personal computer.  The CSV data file was converted using JAMES2DIC into a HTML file format.  Next, the converted HTML file is transformed into the EPWING (Electronic Publishing WING) format using EBStudio.  Finally, we forward the EPWING dictionary file from the personal computer to the iPhone®.  The retrieval becomes possible by using EBPocket for iOS of EPWING/electronic book viewer software for the iPhone®.  The number of items was assumed to be 29 items thought for a lot of inquiries to exist.<br><b>Results: </b>We compared the paper-based formulary with the iPhone® electronic formulary.  As a result, the iPhone4® electronic formulary shortened the retrieval time, was smaller, lighter, and excellent at a lower price.<br><b>Conclusion: </b>The iPhone4® electronic formulary enables the user to perform complex full-text searches and retrieve information at a much higher speed than is possible with paper based formularies.  It has the additional advantage of seamless integration and deployment of formulary additions or reference material revisions.  We believe we have successfully created a practical electronic formulary.

Prescription Status of Potentially Teratogenic Drugs to Women of Childbearing Age in the Emergency Department of a Teaching Hospital

PURPOSE: The purpose of this study is to survey the prescription status of potentially teratogenic drugs to women of childbearing age in an emergency department (ED). In addition, the frequency of documentation of patient's pregnancy status was also evaluated. METHODS: A retrospective study was conducted through the use of warehouse data at a tertiary care center. Women aged 20~39 years who were prescribed drugs that the U.S. Food and Drug Administration (FDA) identifies as class D or X were evaluated. The frequency of prescription of potentially teratogenic drugs and the rate of pregnancy tests performed at the ED were analyzed. RESULTS: Among the 7,742 women of childbearing age with ED visits, 1,962(25.3%) patients received at least one potentially teratogenic drug during 2006, based upon the FDA risk classification system. The most frequently prescribed drugs were non steroidal anti-inflammatory drugs (NSAID) (50.8%), opioid drugs(26.3%), and benzodiazepines(10.3%). The number of pregnancy tests performed before prescribing potentially teratogenic drugs was 838 (39.0%). Among patients for whom a pregnancy test was not performed, only 87(7.6%) patients were advised by their doctors of drug teratogenecity. CONCLUSION: The frequency of prescription of potentially teratogenic drugs to women of childbearing age was 1 in every 4 visits at the ED. In addition, the rates of documentation of pregnancy status and explanation of teratogenecity were relatively low. Introducing a pregnancy information system and a pregnancy alerting system, as well as increasing the frequency of pregnancy tests before prescribing are necessary, not only for pregnant women and fetuses but also for emergency medical personnel at the point of care.